Company News in the Life Science Industry

DUBLIN, June 26, 2019 /PRNewswire/ -- The Read more ››

NEW YORK, June 26, 2019 /PRNewswire/ -- The report on the global paroxysmal nocturnal hemoglobinuria (PNH) treatment market provides qualitative and quantitative analysis for the period from 2017 to 2025.



Read the full report: Read more ››

NEW YORK, June 26, 2019 /PRNewswire/ -- The report on the global needle-free diabetes care market provides qualitative and quantitative analysis for the period from 2017 to 2025.



Read the full report: Read more ››

NEW YORK, June 26, 2019 /PRNewswire/ --

NEW YORK, June 26, 2019 /PRNewswire/ -- The report on the global phenylketonuria treatment market provides qualitative and quantitative analysis for the period from 2017 to 2025.



Read the full report: Read more ››

NEW YORK, June 26, 2019 /PRNewswire/ -- The report on the global smart inhalers market provides qualitative and quantitative analysis for the period from 2017 to 2025.



Read the full report: Read more ››

NEW YORK, June 26, 2019 /PRNewswire/ --

JACKSON, Mich., June 26, 2019 /PRNewswire/ -- Doctors performed the first catheter-based replacement of an aortic heart valve today at Read more ››

DUBLIN, June 26, 2019 /PRNewswire/ -- The Read more ››

DUBLIN, June 26, 2019 /PRNewswire/ -- The Read more ››

NEW ORLEANS, June 26, 2019 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 20, 2019 to file lead plaintiff applications in a securities class action lawsuit against... Read more ››

DUBLIN, June 26, 2019 /PRNewswire/ -- The Read more ››

WINNIPEG, June 26, 2019 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJD.PK), a pharmaceutical company, today announced the results of its annual meeting of shareholders which took place on June 26, 2019. All director nominees were re-appointed... Read more ››

HOUSTON and VANCOUVER, June 26, 2019 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (Nasdaq: EPIX; TSX-V: EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer provides an update, further to the announcement made on May 16, 2019 announcing... Read more ››